Intuitive Surgical, Inc. vs Novartis AG — how do they compare? Intuitive Surgical, Inc. trades at $405.5 (market cap $141.75B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 2.1× Intuitive Surgical, Inc.'s market cap, and Novartis AG pays a 3.07% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | NVS | |
|---|---|---|
Market Cap | $141.75B | $295.37B |
Sector | Health | Health |
52-Week High | $592.85 | $168.62 |
52-Week Low | $332.02 | $119.31 |
Enterprise Value | $136.53B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →